Methylation of Immune Gene Promoters in Oral and Oropharyngeal Cancer
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097698 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Petra Anić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, Srebrnjak Children's Hospital, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Papillomavirus Infections, Oropharyngeal Neoplasms, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, European Social Fund.
Abstract (Originalsprache)
The proportion of oral and oropharyngeal squamous cell carcinoma (OOSCC) that can be attributed to human papillomavirus (HPV) infection is growing nowadays. A potential factor indicating the occurrence of HPV-positive OSCC is a change in the degree of methylation of gene promoters that play a key role in the immune response. In this study, we investigated the difference in the methylation of EDARADD, GBP4, HAVCR2, HLA DPB1, IL12RB1, MARCO, and SIGLEC12 gene promoters in samples of healthy oral mucosa versus samples of oral and oropharyngeal cancer. The presence of HPV infection in samples was examined earlier. To determine the difference in methylation of those gene promotors, isolated and bisulfite-modified DNA was analysed by the methylation-specific PCR method. The investigated gene promoters were found to be more hypomethylated in the oral and oropharyngeal cancer samples in comparison to normal tissue. The proportion of unmethylated gene promoters was similar in HPV-positive and HPV-negative cancers, although the data should be confirmed on a larger set of samples. To conclude, in samples of healthy oral mucosa, the investigated gene promoters were found to be methylated in a high percentage (73.3% to 100%), while in oral and oropharyngeal cancer samples, they were methylated in a low percentage (11.1% to 37%), regardless of HPV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Department, Srebrnjak Children's Hospital, 10000 Zagreb, Croatia.
- Department of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
- Department of Molecular Biology, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
- Department of Maxillofacial Surgery, Clinical Hospital Dubrava, 10000 Zagreb, Croatia.
- Department of Oral Medicine, School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
ORCID-Profile: Ksenija Božinović, Marinka Mravak-Stipetić, Magdalena Grce, Nina Milutin Gašperov
Förderung
- Croatian Science Foundation
- European Social Fund
Zitieren
APA
Anić, P., Golubić Talić, J., Božinović, K., Dediol, E., Mravak-Stipetić, M., Grce, M., & Milutin Gašperov, N. (2023). Methylation of Immune Gene Promoters in Oral and Oropharyngeal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097698
Vancouver
Anić P, Golubić Talić J, Božinović K, Dediol E, Mravak-Stipetić M, Grce M, et al. Methylation of Immune Gene Promoters in Oral and Oropharyngeal Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097698
BibTeX
@article{Ani2023,
author = {Anić, Petra and Golubić Talić, Jasminka and Božinović, Ksenija and Dediol, Emil and Mravak-Stipetić, Marinka and Grce, Magdalena and Milutin Gašperov, Nina},
title = {Methylation of Immune Gene Promoters in Oral and Oropharyngeal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097698}
}
EUVIMED